Literature DB >> 3381924

The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment.

M M Weissman1, P J Leaf, M L Bruce, L Florio.   

Abstract

Data from a survey of five U.S. communities showed that dysthymia affected approximately 3% of the adult population. It was more common in women under age 65, unmarried persons, and young persons with low income and was associated with greater use of general health and psychiatric services and psychotropic drugs. Dysthymia had a high comorbidity with other psychiatric disorders, particularly major depression; only about 25%-30% of cases occur over a lifetime in the absence of other psychiatric disorders. The findings suggest that although the onset and highest risk periods of major depression and bipolar disorder are in young adulthood, a residual state of dysthymia occurs in middle and old age.

Entities:  

Mesh:

Year:  1988        PMID: 3381924     DOI: 10.1176/ajp.145.7.815

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

1.  The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal epidemiological data.

Authors:  C Ernst; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

2.  Surviving social assistance: 12-month prevalence of depression in sole-support parents receiving social assistance.

Authors:  C Byrne; G Browne; J Roberts; B Ewart; M Schuster; J Underwood; S Flynn-Kingston; K Rennick; B Bell; A Gafni; S Watt; Y Ashford; E Jamieson
Journal:  CMAJ       Date:  1998-04-07       Impact factor: 8.262

Review 3.  Successful coping, adaptation and resilience in the elderly: an interpretation of epidemiologic data.

Authors:  J R Foster
Journal:  Psychiatr Q       Date:  1997

4.  Antidepressants normalize the default mode network in patients with dysthymia.

Authors:  Jonathan Posner; David J Hellerstein; Inbal Gat; Anna Mechling; Kristin Klahr; Zhishun Wang; Patrick J McGrath; Jonathan W Stewart; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2013-04       Impact factor: 21.596

Review 5.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Epidemiology of depression.

Authors:  J Angst
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 7.  A comparison of active drugs for the treatment of dysthymia.

Authors:  M Silva de Lima; M Hotopf
Journal:  Cochrane Database Syst Rev       Date:  2003

8.  Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.

Authors:  A V Ravindran; Y Charbonneau; M D Zaharia; K al-Zaid; A Wiens; H Anisman
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

9.  Prevalence of depression in a 55-year-old Finnish population.

Authors:  U Rajala; A Uusimäki; S Keinänen-Kiukaanniemi; S L Kivelä
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-05       Impact factor: 4.328

10.  Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study.

Authors:  Thorsten Barnhofer; Catherine Crane; Emily Hargus; Myanthi Amarasinghe; Rosie Winder; J Mark G Williams
Journal:  Behav Res Ther       Date:  2009-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.